Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: An Observational Follow-up Study of 1st-Line Treatment With Herceptin (Trastuzumab) in Patients With Metastatic Breast Cancer (Post-HERMINE)
This ClinicalTrials.gov update reports the completion and posting of results for an observational follow-up study of first-line trastuzumab …
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples
This clinical trial update reports that a study evaluating HER2 status in breast cancer tissue samples has completed and posted its results,…
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse [NA]
A feasibility study evaluating the use of trastuzumab subcutaneous during follow-up visits led by an Advanced Practice Nurse in breast cance…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: The Impact of Obesity and Obesity Treatments on Breast Cancer [Phase 1]
A Phase 1 clinical trial examined how obesity and obesity treatments affect breast cancer outcomes. The study is listed as completed.
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Bone Response in Metastatic Breast Cancer Involving Bones
This clinical trial update summarizes results from a completed study evaluating bone response in patients with metastatic breast cancer invo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-02-18FDA Approved: CAPECITABINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for capecitabine filed by Teva Pharmaceuticals USA, Inc. (ANDA 091649).
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Lonafarnib in Metastatic Breast Cancer [Phase 2]
This Phase 2 clinical trial update reports results for lonafarnib in metastatic breast cancer, with the study terminated and results posted.
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: TORI 104 Pre-Surgical Dasatinib [Phase 2]
A Phase 2 trial of pre-surgical dasatinib for breast cancer (TORI 104) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Biological Therapy in Treating Women With Stage IV Breast Cancer [Phase 1]
A Phase 1 clinical trial evaluating a biological therapy for women with stage IV breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"
A long-term use survey of Leuprorelin Acetate SR 11.25 mg for injection in premenopausal breast cancer patients (96 weeks) completed with re…
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography
This clinical trial update shows that the prospective chart-review study evaluating the combination of digital breast tomosynthesis and digi…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer [Phase 2, Phase 3]
This update reports on a Phase 2/Phase 3 trial evaluating the addition of carboplatin to neoadjuvant therapy for patients with triple-negati…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) [Phase 3]
Phase 3 PREPARE trial in breast cancer evaluating preoperative combinations of epirubicin, paclitaxel, and darbepoetin alfa (Aranesp) has co…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 [Phase 1]
Phase 1 study ICORG 06-30 evaluating the combination of lapatinib and epirubicin in metastatic breast cancer has completed.
-
CLINICAL_TRIALS research · 2016-02-15Clinical Trial Update: Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients [Phase 2]
Phase 2 trial update on olaparib (Lynparza) for locally advanced triple-negative breast cancer and locally advanced germline BRCA mutation–p…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Investigation of the Pain Relieving Properties of Lipotransplantation After Treatment for Breast Cancer [NA]
A completed clinical trial evaluating whether lipotransplantation relieves chronic pain in patients treated for breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL) [Phase 2]
Phase 2 trial of dichloroacetate (DCA) in previously treated metastatic breast cancer and non-small cell lung cancer was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating Akt inhibitor MK2206 in advanced breast cancer has completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients [Phase 2]
Phase 2 trial of trastuzumab, bevacizumab, and docetaxel in stage IV metastatic breast cancer completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy [EARLY_Phase 1]
A Phase 1 trial update evaluating an imaging biomarker for early detection of treatment efficacy in breast cancer patients undergoing neoadj…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating bevacizumab in combination with paclitaxel versus paclitaxel with placebo as first-line therapy for HER2-negative m…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer [Phase 3]
A Phase 3 trial evaluated a neoadjuvant regimen combining bevacizumab, everolimus (RAD001), and lapatinib for primary breast cancer. The stu…
-
CLINICAL_TRIALS research · 2016-02-10Clinical Trial Update: A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer [Phase 2]
This clinical trial update describes a Phase II study of combining doxorubicin with Genexol-PM in patients with advanced/metastatic breast c…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane [Phase 3]
A Phase 3 trial evaluating continuing everolimus beyond progression after prior everolimus plus exemestane in metastatic breast cancer was t…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast [Phase 2, Phase 3]
This entry notes the completion of a Phase 2/3 clinical trial evaluating adjuvant chemotherapy in elderly non-frail patients with increased …